CYP2A6 Effects on Subjective Reactions to Initial Smoking Attempt

被引:2
|
作者
Cannon, Dale S. [1 ]
Mermelstein, Robin J. [2 ,3 ]
Medina, Tait R. [4 ]
Pugach, Oksana [4 ]
Hedeker, Donald [5 ]
Weiss, Robert B. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Psychiat, 650 Komas Dr,Suite 206, Salt Lake City, UT 84108 USA
[2] Univ Illinois, Inst Hlth Res, Chicago, IL USA
[3] Univ Illinois, Policy & Psychol Dept, Chicago, IL USA
[4] Univ Illinois, Inst Publ Hlth Res & Policy, Chicago, IL USA
[5] Univ Chicago, Dept Hlth Sci, Chicago, IL 60637 USA
[6] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84108 USA
基金
美国国家卫生研究院;
关键词
NICOTINE DEPENDENCE; TOBACCO DEPENDENCE; SMOKERS; ASSOCIATION; ADDICTION; BEHAVIOR; GENES; RISK; ADOLESCENTS; METABOLISM;
D O I
10.1093/ntr/ntv244
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: In very novice smokers, CYP2A6 genotypes that reduce nicotine metabolism to an intermediate rate may increase smoking risk, relative to both normal and slow rates. The present study examined the hypothesis that intermediate metabolism variants are associated with greater pleasurable effects of the initial smoking attempt than either normal or slow metabolism variants. Methods: Participants were novice smokers (N = 261, 65% female) of European descent. Predicted nicotine metabolic rate based on CYP2A6 diplotypes (CYP2A6 Diplotype Predicted Rate [CDPR]) was partitioned into Normal, Intermediate, and Slow categories using a metabolism metric. Subjective reactions to the initial smoking attempt were assessed by the Pleasurable Smoking Experiences (PSE) scale, which was collected within 3 years of the initial smoking attempt. The effect of CDPR on PSE was tested using a generalized linear model in which CDPR was dummy coded and Intermediate CDPR was the reference condition. Gender was included in the model as a control for higher PSE scores by males. Results: Lower PSE scores were associated with Normal CDPR, beta = -0.34, P =.008, and Slow CDPR, beta = -0.52, P =.001, relative to Intermediate CDPR. Conclusions: Intermediate CDPR-enhanced pleasurable effects of the initial smoking attempt relative to other CYP2A6 variants. This finding is consistent with the hypothesis that the risk effect of Intermediate CDPR on early smoking is a function of optimal pleasurable effects. Implications: This study supports our recent hypothesis that CYP2A6 diplotypes that encode intermediate nicotine metabolism rate are associated with enhanced pleasurable events following the initial smoking attempt, compared with diplotypes that encode either normal or slow metabolism. This hypothesis was offered to account for our unexpected previous finding of enhanced smoking risk in very novice smokers associated with intermediate metabolism rate. Our new finding encourages further investigation of time-dependent relations between CYP2A6 effects and smoking motives, and it encourages laboratory study of the mechanisms underlying the initial smoking enhancement in novice smokers associated with intermediate metabolism.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 50 条
  • [1] CYP2A6 genotype and smoking
    J Tiihonen
    U Pesonen
    J Kauhanen
    M Koulu
    T Hallikainen
    L Leskinen
    J T Salonen
    Molecular Psychiatry, 2000, 5 : 347 - 348
  • [2] CYP2A6 genotype and smoking
    Tiihonen, J
    Pesonen, U
    Kauhanen, J
    Koulu, M
    Hallikainenz, T
    Leskinen, L
    Salonen, T
    MOLECULAR PSYCHIATRY, 2000, 5 (04) : 347 - 348
  • [3] Whole deletion of CYP2A6 gene (CYP2A6*4C) and smoking behavior
    Iwahashi, K
    Waga, C
    Takimoto, T
    NEUROPSYCHOBIOLOGY, 2004, 49 (02) : 101 - 104
  • [4] Inhibition of CYP2A6 decreases smoking.
    Sellers, EM
    Kaplan, HL
    Romach, MK
    Tyndale, RF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 153 - 153
  • [5] An association of CYP2A6 genotype and smoking topography
    Strasser, Andrew A.
    Malaiyandi, Viba
    Hoffmann, Ewa
    Tyndale, Rachel F.
    Lerman, Caryn
    NICOTINE & TOBACCO RESEARCH, 2007, 9 (04) : 511 - 518
  • [6] CYP2A6 genotype and cigarette smoking.
    Tiihonen, J
    Pesonen, U
    Kauhanen, J
    Koulu, M
    Hallikainen, T
    Leskinen, L
    Salonen, JT
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 519 - 519
  • [7] Smoking cessation program and CYP2A6 polymorphism
    Ozaki, Shinichi
    Oyama, Tsunehiro
    Isse, Toyohi
    Kagawa, Norio
    Uramoto, Hidetaka
    Sugio, Kenji
    Yasumoto, Kosei
    Kono, Keizo
    Kawamoto, Toshihiro
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2590 - 2597
  • [8] ASSOCIATIONS BETWEEN CYP2A6 VARIANTS AND SMOKING BEHAVIORS
    Styn, Mindi A.
    Nukui, Tomoko
    Romkes, Marjorie
    Weissfeld, Joel L.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 219 - 219
  • [9] Duplications and defects in the CYP2A6 gene:: Identification, genotyping, and in vivo effects on smoking
    Rao, YS
    Hoffmann, E
    Zia, M
    Bodin, L
    Zeman, M
    Sellers, EM
    Tyndale, RF
    MOLECULAR PHARMACOLOGY, 2000, 58 (04) : 747 - 755
  • [10] Genetic variation of CYP2A6, smoking, and risk of cancer
    London, SJ
    Idle, JR
    Daly, AK
    Coetzee, GA
    LANCET, 1999, 353 (9156): : 898 - 899